AKT1 and Hepatic fibrosis: The mammalian target of rapamycin (mTOR), a critical regulator of autophagy and a downstream effector of the PI3K/AKT pathway, is known to negatively regulate autophagy and plays a significant role in the pathogenesis of liver fibrosis [35–39].